Loading…
More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates
Saved in:
Published in: | Journal of antimicrobial chemotherapy 2012-04, Vol.67 (4), p.1048-1049 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53 |
---|---|
cites | cdi_FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53 |
container_end_page | 1049 |
container_issue | 4 |
container_start_page | 1048 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 67 |
creator | Martín-Gandul, Cecilia García-Cabrera, Emilio Castillo-Ojeda, Esperanza Jiménez-Mejías, Manuel E. |
description | |
doi_str_mv | 10.1093/jac/dkr556 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_927989408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jac/dkr556</oup_id><sourcerecordid>927989408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53</originalsourceid><addsrcrecordid>eNp90MtOxCAUBmBiNM542fgAphtjYlKHQingzky8JWPc6Lqh9KAd2zICXczby9ycnRtI4MvP4UfoIsO3GZZ0Mld6Un87xooDNM7yAqcEy-wQjTHFLOU5oyN04v0cY1ywQhyjESEEcyb5GNlX6yBRlR1CEr4g8cpAWCbWJKH5BL3UbdNDYqxb3wYHKnTQhxVoegM6NHbwSd14UB783Vo528IK-GEBbqf6xKkA_gwdGdV6ON_up-jj8eF9-pzO3p5epvezVFNBQgo8F4bldUFzrnIlRS4AMlFlmvJaE65JVselkBWP38ayAkqLeAiiYIYYRk_R9SZ34ezPAD6UXeM1tK3qIU5cSsKlkDkWUd5spHbWewemXLimU25ZZrhc9VvGfstNvxFfbmOHqoP6j-4KjeBqC5TXqjVO9brxexczuJRy7-yw-O_BX_vPkXs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>927989408</pqid></control><display><type>article</type><title>More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates</title><source>Oxford Journals Online</source><creator>Martín-Gandul, Cecilia ; García-Cabrera, Emilio ; Castillo-Ojeda, Esperanza ; Jiménez-Mejías, Manuel E.</creator><creatorcontrib>Martín-Gandul, Cecilia ; García-Cabrera, Emilio ; Castillo-Ojeda, Esperanza ; Jiménez-Mejías, Manuel E.</creatorcontrib><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkr556</identifier><identifier>PMID: 22207597</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - adverse effects ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Infections - drug therapy ; Biological and medical sciences ; Female ; Humans ; Incidence ; Male ; Medical sciences ; Middle Aged ; Minocycline - administration & dosage ; Minocycline - adverse effects ; Minocycline - analogs & derivatives ; Pharmacology. Drug treatments ; Superinfection - epidemiology ; Young Adult</subject><ispartof>Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.1048-1049</ispartof><rights>The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53</citedby><cites>FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25637999$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22207597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martín-Gandul, Cecilia</creatorcontrib><creatorcontrib>García-Cabrera, Emilio</creatorcontrib><creatorcontrib>Castillo-Ojeda, Esperanza</creatorcontrib><creatorcontrib>Jiménez-Mejías, Manuel E.</creatorcontrib><title>More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Infections - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Minocycline - administration & dosage</subject><subject>Minocycline - adverse effects</subject><subject>Minocycline - analogs & derivatives</subject><subject>Pharmacology. Drug treatments</subject><subject>Superinfection - epidemiology</subject><subject>Young Adult</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp90MtOxCAUBmBiNM542fgAphtjYlKHQingzky8JWPc6Lqh9KAd2zICXczby9ycnRtI4MvP4UfoIsO3GZZ0Mld6Un87xooDNM7yAqcEy-wQjTHFLOU5oyN04v0cY1ywQhyjESEEcyb5GNlX6yBRlR1CEr4g8cpAWCbWJKH5BL3UbdNDYqxb3wYHKnTQhxVoegM6NHbwSd14UB783Vo528IK-GEBbqf6xKkA_gwdGdV6ON_up-jj8eF9-pzO3p5epvezVFNBQgo8F4bldUFzrnIlRS4AMlFlmvJaE65JVselkBWP38ayAkqLeAiiYIYYRk_R9SZ34ezPAD6UXeM1tK3qIU5cSsKlkDkWUd5spHbWewemXLimU25ZZrhc9VvGfstNvxFfbmOHqoP6j-4KjeBqC5TXqjVO9brxexczuJRy7-yw-O_BX_vPkXs</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Martín-Gandul, Cecilia</creator><creator>García-Cabrera, Emilio</creator><creator>Castillo-Ojeda, Esperanza</creator><creator>Jiménez-Mejías, Manuel E.</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates</title><author>Martín-Gandul, Cecilia ; García-Cabrera, Emilio ; Castillo-Ojeda, Esperanza ; Jiménez-Mejías, Manuel E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Infections - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Minocycline - administration & dosage</topic><topic>Minocycline - adverse effects</topic><topic>Minocycline - analogs & derivatives</topic><topic>Pharmacology. Drug treatments</topic><topic>Superinfection - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martín-Gandul, Cecilia</creatorcontrib><creatorcontrib>García-Cabrera, Emilio</creatorcontrib><creatorcontrib>Castillo-Ojeda, Esperanza</creatorcontrib><creatorcontrib>Jiménez-Mejías, Manuel E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martín-Gandul, Cecilia</au><au>García-Cabrera, Emilio</au><au>Castillo-Ojeda, Esperanza</au><au>Jiménez-Mejías, Manuel E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>67</volume><issue>4</issue><spage>1048</spage><epage>1049</epage><pages>1048-1049</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22207597</pmid><doi>10.1093/jac/dkr556</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.1048-1049 |
issn | 0305-7453 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_927989408 |
source | Oxford Journals Online |
subjects | Adolescent Adult Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial Infections - drug therapy Biological and medical sciences Female Humans Incidence Male Medical sciences Middle Aged Minocycline - administration & dosage Minocycline - adverse effects Minocycline - analogs & derivatives Pharmacology. Drug treatments Superinfection - epidemiology Young Adult |
title | More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A59%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=More%20about%20the%20safety%20of%20tigecycline%20for%20the%20treatment%20of%20infectious%20diseases:%20the%20role%20of%20superinfection%20rates&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Mart%C3%ADn-Gandul,%20Cecilia&rft.date=2012-04-01&rft.volume=67&rft.issue=4&rft.spage=1048&rft.epage=1049&rft.pages=1048-1049&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/dkr556&rft_dat=%3Cproquest_cross%3E927989408%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-e748f54d6347a4a9848ee18b1c37dc27c21d7c269b755609be336c21e865f2f53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=927989408&rft_id=info:pmid/22207597&rft_oup_id=10.1093/jac/dkr556&rfr_iscdi=true |